- Home
- PSF vs GNFT Comparison
PSF vs GNFT Comparison
Compare PSF & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSF
- GNFT
- Stock Information
- Founded
- PSF 2010
- GNFT 1999
- Country
- PSF United States
- GNFT France
- Employees
- PSF N/A
- GNFT N/A
- Industry
- PSF Investment Managers
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSF Finance
- GNFT Health Care
- Exchange
- PSF Nasdaq
- GNFT Nasdaq
- Market Cap
- PSF 251.0M
- GNFT 216.7M
- IPO Year
- PSF N/A
- GNFT 2019
- Fundamental
- Price
- PSF $20.79
- GNFT $4.26
- Analyst Decision
- PSF
- GNFT Strong Buy
- Analyst Count
- PSF 0
- GNFT 2
- Target Price
- PSF N/A
- GNFT $10.00
- AVG Volume (30 Days)
- PSF 25.0K
- GNFT 7.2K
- Earning Date
- PSF 01-01-0001
- GNFT 09-22-2025
- Dividend Yield
- PSF 7.69%
- GNFT N/A
- EPS Growth
- PSF N/A
- GNFT N/A
- EPS
- PSF N/A
- GNFT N/A
- Revenue
- PSF N/A
- GNFT $52,994,715.00
- Revenue This Year
- PSF N/A
- GNFT $3.14
- Revenue Next Year
- PSF N/A
- GNFT N/A
- P/E Ratio
- PSF N/A
- GNFT N/A
- Revenue Growth
- PSF N/A
- GNFT N/A
- 52 Week Low
- PSF $16.00
- GNFT $2.55
- 52 Week High
- PSF $20.19
- GNFT $6.03
- Technical
- Relative Strength Index (RSI)
- PSF 52.95
- GNFT 54.99
- Support Level
- PSF $20.66
- GNFT $4.08
- Resistance Level
- PSF $20.83
- GNFT $4.40
- Average True Range (ATR)
- PSF 0.16
- GNFT 0.16
- MACD
- PSF -0.01
- GNFT 0.02
- Stochastic Oscillator
- PSF 63.59
- GNFT 67.24
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.